ArticleThe Lancet regional health. Europe2026
Clinical characteristics and factors contributing to transmission of congenital syphilis in England, 2015-24: a national surveillance study.
Article in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Congenital syphilis has re-emerged in England despite near-universal antenatal screening coverage, indicating that important opportunities for prevention continue to be missed. We aimed to characterise the clinical presentation, diagnostic findings, and factors contributing to transmission among congenital syphilis cases in England to inform strategies for earlier diagnosis and prevention. Methods: We reviewed probable and confirmed congenital syphilis cases in England (January 2015 to June 2024) reported through the Integrated Screening Outcomes Surveillance Service, including maternal and infant demographic, clinical, laboratory, treatment, and outcome data. Findings: Among 67 cases there were 54 livebirths, including five neonatal deaths, and 13 stillbirths. Common manifestations included hepatosplenomegaly, rash, bone abnormalities, thrombocytopaenia and jaundice. Neonatal IgM was positive in 81% (34/42), whereas only 24% (10/41) of mother-infant pairs demonstrated the expected four-fold higher non-treponemal titre in the infant. PCR was positive in 87% (13/15) of those tested but was used infrequently. Nearly half of cases (32/67, 48%) occurred in infants whose mothers had screened negative antenatally but acquired syphilis during pregnancy. Maternal symptoms were often overlooked, and some infants were initially treated for presumed sepsis without syphilis testing. Other cases were associated with late antenatal booking, incomplete treatment, difficulties engaging with maternity services, and complex social circumstances. Interpretation: Congenital syphilis in England remains associated with substantial morbidity and mortality. Maternal infection acquired during pregnancy, missed diagnostic opportunities, and social vulnerability contribute to transmission. Greater clinical vigilance, wider use of PCR, improved engagement with vulnerable women, and consideration of universal third-trimester screening could strengthen prevention efforts. Funding: Funding was received from the Sexually Transmitted Infection Research Foundation, United Kingdom.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.